|
The world's largest Muslim nation, Indonesia has been struggling for several years to increase its rice production (SeedQuest)
Efforts by Indonesia to avoid food shortages by increasing its rice production have received an important boost with the signing of a new agreement to help the nation's millions of poor rice farmers with new technologies.
(Apr 4, 2007)
More News (Gazette.Net)
The future of the Germantown biopharma may depend on Food and Drug Administration approval of the company’s resubmitted drug application for its lead investigative drug, Amoxicillin Pulsys, but that may not come until next January or later.
(Apr 4, 2007)
Invitrogen Sales Force Most Visible (PRWeb via Yahoo! News)
According to the findings of a recent study, Invitrogen has the most visible sales force among life scientists. The study also reports that GE Healthcare has the greatest percent of "promoters" due to the influence of their sales force.
(Apr 4, 2007)
AnaSpec Introduces AnaTag™ Protein Labeling Kits (PR.com)
The labeling of proteins and antibodies with fluorescent dyes can play a crucial role in flow cytometry, immunohistochemistry and fluorescent in-situ hybridization techniques. Incorporating its high performance HiLyte Fluor™ dyes in a ready-to-use kit, AnaSpec has introduce its new line of AnaTag™ Protein Labeling Kits as a convenient method for labeling proteins with AnaSpec dyes. AnaTag™ ...
(Apr 4, 2007)
Invitrogen Sales Force Most Visible (PR Web)
According to the findings of a recent study, Invitrogen has the most visible sales force among life scientists. The study also reports that GE Healthcare has the greatest percent of "promoters" due to the influence of their sales force. (PRWeb Apr 4, 2007) Post Comment:Trackback URL: http://www.prweb.com/pingpr.ph
(Apr 4, 2007)
New Science Of Metagenomics 'will Transform Modern Microbiology' (Medical News Today)
The emerging field of metagenomics, where the DNA of entire communities of microbes is studied simultaneously, presents the greatest opportunity -- perhaps since the invention of the microscope -- to revolutionize understanding of the microbial world, says a new report from the National Research Council. [click link for full article]
(Apr 4, 2007)
DNAPrint(TM) Genomics' Advancements in PT-401 and Statinome Presented at Clinical Pharmacology Conference (Market Wire via Yahoo! Finance)
DNAPrint(TM) Genomics, Inc. today reported that several advancements in its proprietary DNA research on PT-401 and Statinome formed the basis for three papers that were presented by DNAPrint Chairman and Chief Medical Officer Hector J.
(Apr 4, 2007)
Power3 Medical and NeoGenomics to Form Contract Research Organization (Business Wire via Yahoo! Finance)
HOUSTON----Power3 Medical Products, Inc. , announced today that it has entered into a collaboration agreement with NeoGenomics, Inc. of Fort Myers, Florida, to form a joint venture Contract Research Organization .
(Apr 4, 2007)
Nanogen Obtains GSA Contract for NanoChip(R) 400 Platform (Business Wire via Yahoo! Finance)
SAN DIEGO----Nanogen, Inc. , developer of advanced diagnostic products, announced today that it has obtained a United States Government Service Administration Schedule contract. The contract, number GS-07F-0283T, applies to the company's NanoChip® 400 microarray instrument and reagents.
(Apr 4, 2007)
U.S. Corn Seeds and Traits Business Leads Strong Second-Quarter and First-Half Performance for Monsanto Company (PR Newswire via Yahoo! Finance)
in millions)
(Apr 4, 2007)
BIOCOM Announces New Board Members (PR Newswire via Yahoo! Finance)
BIOCOM, the association for the Southern California life science community, is pleased to announce eight new members of its 2007-2008 Board of Directors, representing the leadership of the life science industry.
(Apr 4, 2007)
Elsevier Launches New Journal 'Marine Genomics' (Medical News Today)
Elsevier announced recently the launch of a new journal, Marine Genomics. The journal will be published quarterly, and will focus on the advances in the very rapidly expanding field of genomic studies on marine organisms. The first issue will appear in March 2008. Prof. William Martin, Group Director at Heinrich-Heine University in Dusseldorf (Germany) will be the Co-Editor of the new journal. ...
(Apr 4, 2007)
Local lab joins Houston co. for disease research (The News-Press)
NeoGenomics, Inc.
(Apr 4, 2007)
Almac Announces New Research on Colorectal Pre-Malignancies (Newswise)
Today, Almac Diagnostics announced a major study analysing colorectal polyp tissue samples using its novel Colorectal Cancer DSA(tm) microarray. The DSA(tm) research tool focuses on the transcriptome of an individual disease, in this case colorectal cancer, and contains significant additional data, relevant to the disease of interest that is not available on other generic microarrays.
(Apr 4, 2007)
SciGene, Baylor Start Microarray Collaboration to Improve BeadChip Processing (GenomeWeb News)
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription.
(Apr 4, 2007)
St. Louis, Missouri April 4, 2007 (SeedQuest)
"While the 2007 agriculture season is shaping up to be an outstanding one, the strong demand that we've seen for our higher-yielding corn seeds and our higher-margin, triple-trait corn technology has translated into an excellent second quarter and first half for our business.
(Apr 4, 2007)
Narrow Based ETFs: For the Right Time and Place (SeekingAlpha via Yahoo! Finance)
Roger Nusbaum submits: Yes, yet another article from Morningstar shunning anything innovative, and showing the extent to which they don't understand the ETF market. A lot of ink is devoted to picking on the HealthShare ETFs.
(Apr 4, 2007)
DNAPrint(TM) Genomics' Advancements in PT-401 and Statinome Presented at Clinical Pharmacology Conference (RedNova)
DNAPrint(TM) Genomics, Inc. (OTCBB: DNAG) today reported that several advancements in its proprietary DNA research on PT-401 and Statinome formed the basis for three papers that were presented by DNAPrint Chairman and Chief Medical Officer Hector J.
(Apr 4, 2007)
NIH Neuroscience Microarray Consortium Launches High-throughput Genotyping Services (Medical News Today)
The NIH Neuroscience Microarray Consortium has announced that it has added high-density genotyping on both the Affymetrix and Illumina platforms to its list of services. [click link for full article]
(Apr 4, 2007)
The United States is Expected to Account for 40% of the World's Metabolomics Market by 2008 (Business Wire via Yahoo! Finance)
DUBLIN, Ireland----Research and Markets has announced the addition of Metabolomics - A Market Insight Report to their offering.
(Apr 4, 2007)
NeoGenomics and Power3 Medical Products to Form Joint Venture Contract Research Organization (RedNova)
FT. MYERS, Fla., April 4 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (BULLETIN BOARD: NGNM) announced today that it has concluded an agreement with Power3 Medical Products, Inc. (OTC PK: PWRM) to form a joint venture Contract Research Organization (CRO).
(Apr 4, 2007)
Biosite Reports On Presentation Of Preliminary Data From Sepsis Program (Medical News Today)
Biosite Incorporated (Nasdaq:BSTE) has announced preliminary results of a sample collection study aimed at identifying a biomarker panel that could potentially aid in the assessment for risk of sepsis progression. Sepsis is an often fatal condition with limited therapeutic options. Clinical investigator, Emanuel P. Rivers, M.D. [click link for full article]
(Apr 4, 2007)
Monsanto raises outlook amid "stellar year" for corn (Market Watch)
SAN FRANCISCO (MarketWatch) -- More farmers hopping on the ethanol bandwagon helped propel Monsanto Co.'s earnings higher, prompting the seed company to raise its outlook for what executives called a "stellar year" for corn on Wednesday.
(Apr 4, 2007)
ICSI Releases XORP 1.4 (Newswise)
The International Computer Science Institute (ICSI) has announced Release 1.4 of XORP, the eXtensible Open Router Platform. The software is available for download at www.xorp.org.
(Apr 4, 2007)
Thallion Pharmaceuticals Inc. Announces its Operating Highlights and Presents Ecopia's Financial Results for the First ... (Market Wire via Yahoo! Finance)
Thallion Pharmaceuticals Inc. today reviewed recent operating highlights and announced the financial results for Ecopia's first quarter ended February 28, 2007. Today's announcement represents the last report of Ecopia's financial results consistent with current regulatory requirements after which we will review and announce future operating highlights and financial results as Thallion ...
(Apr 4, 2007)
Thallion Pharmaceuticals Inc. Announces its Operating Highlights and Presents Ecopia's Financial Results for the First ... (CCNMatthews via Yahoo! Finance)
MONTREAL, QUEBEC-- - Thallion Pharmaceuticals Inc. today reviewed recent operating highlights and announced the financial results for Ecopia's first quarter ended February 28, 2007.
(Apr 4, 2007)
Exagen Diagnostics, Inc.(TM) Leads Next Phase of Genomics Revolution (Business Wire via Yahoo! Finance)
ALBUQUERQUE, N.M.----Exagen Diagnostics, Inc. today announced that it filed for U.S. Food and Drug Administration review of the first of six products currently in the Exagen pipeline.
(Apr 4, 2007)
Mr. Martin LeBlanc becomes a Director of Victhom (CNW Group via Yahoo! Finance)
Victhom Human Bionics Inc., , announced today that Mr. Martin LeBlanc had joined its Board of Directors on March 23rd, 2007. "Mr. LeBlanc will be bringing exceptional expertise to Victhom, and his experience will be especially relevant and useful for the future development of the Company" said Mr.
(Apr 4, 2007)
Biocom announces new board members (San Diego Daily Transcript via Yahoo! News)
Biocom, an association for the life science community, has announced eight new members of its 2007-2008 board of directors.
(Apr 5, 2007)
New beer in wine bottles: NVIDIA to rebrand G80 as supercomputer chip (Ars Technica)
Rumor has it that NVIDIA will start a new branding effort for the G80, aimed at selling the GPU to the supercomputer market. I think they've got a message problem that this new effort will solve. Read More...
(Apr 5, 2007)
NeoGenomics to develop tests (The News-Press)
Fort Myers-based NeoGenomics Inc.
(Apr 5, 2007)
New Companies Find Home in WVU Incubator (WTRF)
Intellectual property created at West Virginia University has potential to bring new jobs, income to the state.
(Apr 5, 2007)
Marshall Sees Tech Transfer as Growth Path (WTRF)
Kopp sees MIIR, entrepreneurial research as ways to keep our college-educated citizens in West Virginia.
(Apr 5, 2007)
Ahead of the Bell: Monsanto (AP via Yahoo! Finance)
A Goldman Sachs analyst hiked his price target on Monsanto Co. after the world's largest seed company reported higher second-quarter profit on robust demand for corn seeds.
(Apr 5, 2007)
Vicki Nienaber Joins ActiveSight, Strengthening Their Structure-Based Drug Design Services (PR Newswire via Yahoo! Finance)
ActiveSight, a division of Rigaku Americas Corporation, announced today that Vicki Nienaber, Ph.D., a pioneer in the development of fragment-based screening for drug discovery, has joined as the Chief Scientific Officer .
(Apr 5, 2007)
Wall Street Breakfast (SeekingAlpha via Yahoo! Finance)
What you need to know before the open today.
(Apr 5, 2007)
Biosite Incorporated Receives Unsolicited Letter from Inverness Medical Regarding Possible Cash Merger Transaction (PR Newswire via Yahoo! Finance)
Biosite Incorporated today announced receipt of an unsolicited letter from Inverness Medical Innovations, Inc. in which Inverness indicates that it is prepared to offer to acquire all of Biosite's outstanding common stock, other than the approximately 4.9% of Biosite shares Inverness already owns, in a cash merger for $90.00 per share.
(Apr 5, 2007)
Exagen Diagnostics, Inc. Leads Next Phase Of Genomics Revolution (BioresearchOnline)
Exagen Diagnostics, Inc. today announced that it filed for U.S. Food and Drug Administration (FDA) review of the first of six products currently in the Exagen pipeline. This product, eXagenBC, is a DNA-based test that identifies risk of recurrence in breast cancer patients and allows physicians to more accurately predict prognostic outcome
(Apr 5, 2007)
Research funding up 11.5 percent (UB Reporter)
After several years of moderate increases, the rate of growth of total research and development expenditures at UB more than tripled during the 2006 fiscal year (FY 2006).
(Apr 5, 2007)
The Human Metabolome Project Contretemps (Bio-IT World)
April 05, 2007 | Earlier this year, David Wishart and colleagues at the University of Alberta published the Human Metabolome Database (HMDB), funded by a multi-million dollar Canadian grant for the "Human Metabolome Project."
(Apr 5, 2007)
Scripps research scientists identify new regulatory mechanism for critical protein signaling domain (EurekAlert!)
The study is being published in Science Express, an advanced online edition of the journal Science, on April 5. It will appear in the print version of Science later this spring.
(Apr 5, 2007)
Researchers identify gene involved in dog size (EurekAlert!)
An international team led by researchers from the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), has identified a genetic variant that is a major contributor to small size in dogs.
(Apr 5, 2007)
Weak immune response critical to disease that causes most infant hospitalizations (EurekAlert!)
GALVESTON, Texas -- The most common cause of infant hospitalization in the United States, respiratory syncytial virus, infects virtually all children by age two.
(Apr 5, 2007)
Nanogen Gains Federal Contract (San Diego Business Journal)
Shares of Nanogen Inc. jumped on April 5 after the company announced that it obtained a United States General Services Administration schedule contract for its NanoChip 400 microarray instrument and reagents.
(Apr 5, 2007)
Fraser-Liggett to Start New Genomics Institute at UMB Biopark (GenomeWeb News)
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription.
(Apr 5, 2007)
Renowned microbiologist Fraser-Liggett to head UMB genome institute (BizJournals)
The University of Maryland School of Medicine could open the doors on a new genome institute by early spring, headed up by a scientist from Washington-based research facility.
(Apr 5, 2007)
What Makes Little Dogs Small? Researchers Identify Gene Involved In Dog Size (Science Daily)
An international team led by researchers has identified a genetic variant that is a major contributor to small size in dogs. The researchers explored the genetic basis for size variation among dogs by comparing the DNA of various small dog breeds, including Chihuahuas, Toy Fox Terriers and Pomeranians, to an array of larger dog breeds, including Irish Wolfhounds, Saint Bernards and Great Danes.
(Apr 5, 2007)
Invitrogen Sets First Quarter Earnings Release Date for Tuesday, May 1, 2007 (Business Wire via Yahoo! Finance)
CARLSBAD, Calif.----Invitrogen Corporation will announce its first quarter 2007 earnings on Tuesday, May 1, 2007, after markets close. Following the earnings release, Invitrogen senior management will hold a live webcast at 5:00 PM to discuss financial and other business results.
(Apr 5, 2007)
World class scientist to lead U-Md.’s new genomics center (The Daily Record)
The University of Maryland School of Medicine said Thursday it has lured a world-class scientist to establish a genomics research center at its West Side BioPark.
(Apr 5, 2007)
U of M student housing planned for downtown (Post-Bulletin)
As workers prepare the Galleria Mall in downtown Rochester for university classes this fall, plans for student housing are quietly taking shape.
(Apr 6, 2007)
|
